CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-01 | 2022-09-01 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $8.92 | +30.3K | 15.7K | New | +$270.2K |
| D | 2022-08-19 | 2022-08-17 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-08-19 | 2022-08-17 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $50.11 | -10.0K | 409.1K | -2% | -$501.1K |
| D | 2022-08-08 | 2022-08-05 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $50.00 | -11.4K | 12.6K | -48% | -$571.4K |
| D | 2022-08-08 | 2022-08-05 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $8.75 | +11.4K | 24.0K | +91% | +$100.0K |
| D | 2022-08-03 | 2022-08-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $41.26 | -10.0K | 409.1K | -2% | -$412.6K |
| D | 2022-08-03 | 2022-08-01 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-07-20 | 2022-07-18 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.5K | +2% | +$79.6K |
| D | 2022-07-20 | 2022-07-18 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $40.49 | -10.0K | 409.5K | -2% | -$404.9K |
| D | 2022-07-14 | 2022-07-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +21.5K | 189.8K | +13% | +$207.5K |
| D | 2022-07-14 | 2022-07-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $43.43 | -21.5K | 168.3K | -11% | -$933.7K |
| 2022-07-12 | 2022-07-01 | CYTK | Bhanji Muna | Dir | A - Grant | $41.00 | +274 | 10.8K | +3% | +$11.2K | |
| 2022-07-12 | 2022-07-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $41.00 | +137 | 11.3K | +1% | +$5,617 | |
| 2022-07-12 | 2022-07-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $41.00 | +137 | 12.2K | +1% | +$5,617 | |
| 2022-07-12 | 2022-07-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $41.00 | +487 | 24.0K | +2% | +$20.0K | |
| 2022-07-12 | 2022-07-01 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $41.00 | +137 | 12.2K | +1% | +$5,617 | |
| 2022-07-12 | 2022-07-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $41.00 | +274 | 12.6K | +2% | +$11.2K | |
| D | 2022-07-08 | 2022-07-06 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.5K | +2% | +$79.6K |
| D | 2022-07-08 | 2022-07-06 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $44.38 | -10.0K | 409.5K | -2% | -$443.8K |
| D | 2022-06-17 | 2022-06-15 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $39.40 | -10.0K | 409.5K | -2% | -$394.0K |
| D | 2022-06-17 | 2022-06-15 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.5K | +2% | +$79.6K |
| D | 2022-06-10 | 2022-06-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $40.62 | -21.5K | 168.3K | -11% | -$873.3K |
| D | 2022-06-10 | 2022-06-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +21.5K | 189.8K | +13% | +$207.5K |
| D | 2022-06-08 | 2022-06-06 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $41.23 | -10.0K | 409.5K | -2% | -$412.3K |
| D | 2022-06-08 | 2022-06-06 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.5K | +2% | +$79.6K |
| D | 2022-05-18 | 2022-05-16 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-05-18 | 2022-05-16 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $43.11 | -10.0K | 409.1K | -2% | -$431.1K |
| D | 2022-05-12 | 2022-05-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $37.54 | -14.0K | 168.1K | -8% | -$525.1K |
| D | 2022-05-12 | 2022-05-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $9.65 | +14.0K | 182.1K | +8% | +$135.0K |
| D | 2022-05-11 | 2022-05-10 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $0.00 | +5,000 | 12.0K | +71% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +5,000 | 11.1K | +81% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | Bhanji Muna | Dir | A - Grant | $0.00 | +5,000 | 10.5K | +90% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +5,000 | 12.3K | +68% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $0.00 | +5,000 | 23.6K | +27% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,000 | 10.0K | +100% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $0.00 | +5,000 | 12.0K | +71% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | COSTA SANTO J | Dir | A - Grant | $0.00 | +5,000 | 10.0K | +100% | $0 |
| D | 2022-05-11 | 2022-05-10 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 |
| D | 2022-05-06 | 2022-05-04 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $39.43 | -10.0K | 409.1K | -2% | -$394.3K |
| D | 2022-05-06 | 2022-05-04 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-04-22 | 2022-04-20 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $37.89 | -10.0K | 409.1K | -2% | -$378.9K |
| D | 2022-04-22 | 2022-04-20 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-04-07 | 2022-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $42.58 | -23.1K | 168.1K | -12% | -$985.6K |
| D | 2022-04-07 | 2022-04-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.00 | +23.1K | 191.2K | +14% | +$138.9K |
| D | 2022-04-06 | 2022-04-04 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $38.78 | -10.0K | 409.1K | -2% | -$387.8K |
| D | 2022-04-06 | 2022-04-04 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| DM | 2022-04-06 | 2022-04-04+ | CYTK | Jaw Ching | CFO, SVP Fin | S - Sale+OE | $40.80 | -25.0K | 67.1K | -27% | -$1.02M |
| DM | 2022-04-06 | 2022-04-04+ | CYTK | Jaw Ching | CFO, SVP Fin | M - OptEx | $12.10 | +25.0K | 82.1K | +44% | +$302.5K |
| 2022-04-01 | 2022-04-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $38.38 | +293 | 7,302 | +4% | +$11.2K | |
| 2022-04-01 | 2022-04-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $38.38 | +146 | 7,033 | +2% | +$5,603 | |
| 2022-04-01 | 2022-04-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $38.38 | +488 | 18.6K | +3% | +$18.7K | |
| 2022-04-01 | 2022-04-01 | CYTK | Bhanji Muna | Dir | A - Grant | $38.38 | +293 | 5,537 | +6% | +$11.2K | |
| 2022-04-01 | 2022-04-01 | CYTK | SMITH SANDFORD D | Dir | A - Grant | $38.38 | +146 | 7,033 | +2% | +$5,603 | |
| 2022-04-01 | 2022-04-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $38.38 | +146 | 6,149 | +2% | +$5,603 | |
| D | 2022-03-23 | 2022-03-21 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 419.1K | +2% | +$79.6K |
| D | 2022-03-23 | 2022-03-21 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $36.03 | -10.0K | 409.1K | -2% | -$360.3K |
| DM | 2022-03-15 | 2022-03-15 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | M - OptEx | $10.67 | +60.8K | 98.6K | +161% | +$648.6K |
| D | 2022-03-15 | 2022-03-15 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | S - Sale+OE | $33.96 | -25.2K | 103.4K | -20% | -$855.7K |
| D | 2022-03-10 | 2022-03-10 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.00 | +26.9K | 194.9K | +16% | +$161.1K |
| D | 2022-03-10 | 2022-03-10 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $37.82 | -26.9K | 168.1K | -14% | -$1.02M |
| D | 2022-03-09 | 2022-03-09 | CYTK | Jaw Ching | CFO, SVP Fin | M - OptEx | $12.10 | +15.0K | 82.1K | +22% | +$181.5K |
| D | 2022-03-09 | 2022-03-09 | CYTK | Jaw Ching | CFO, SVP Fin | S - Sale+OE | $38.00 | -15.0K | 67.1K | -18% | -$570.0K |
| 2022-03-08 | 2022-03-07 | CYTK | Wong Robert | VP, CAO | F - Tax | $36.83 | -1,384 | 32.0K | -4% | -$51.0K | |
| 2022-03-08 | 2022-03-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $36.83 | -9,916 | 168.1K | -6% | -$365.2K | |
| 2022-03-08 | 2022-03-07 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $36.83 | -5,510 | 67.1K | -8% | -$202.9K | |
| 2022-03-08 | 2022-03-07 | CYTK | Cragg David | Chief HR, Admin Off | F - Tax | $36.83 | -5,399 | 153.2K | -3% | -$198.8K | |
| 2022-03-08 | 2022-03-07 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $36.83 | -23.8K | 409.1K | -5% | -$876.5K | |
| 2022-03-08 | 2022-03-07 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | F - Tax | $36.83 | -4,631 | 67.8K | -6% | -$170.6K | |
| D | 2022-03-04 | 2022-03-02 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 442.9K | +2% | +$79.6K |
| D | 2022-03-04 | 2022-03-02 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $36.31 | -10.0K | 432.9K | -2% | -$363.1K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +30.0K | 178.0K | +20% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $37.63 | -5,004 | 148.0K | -3% | -$188.3K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +20.0K | 26.2K | +323% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $37.63 | -3,458 | 52.6K | -6% | -$130.1K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Jaw Ching | CFO, SVP Fin | A - Grant | $0.00 | +20.0K | 72.6K | +38% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Cragg David | Chief HR, Admin Off | A - Grant | $0.00 | +20.0K | 158.6K | +14% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Cragg David | Chief HR, Admin Off | F - Tax | $37.63 | -3,458 | 138.6K | -2% | -$130.1K |
| D | 2022-03-03 | 2022-03-02 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | A - Grant | $0.00 | +20.0K | 72.4K | +38% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | F - Tax | $37.63 | -3,457 | 52.4K | -6% | -$130.1K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $37.63 | -15.9K | 347.9K | -4% | -$597.0K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +85.0K | 432.9K | +24% | $0 |
| D | 2022-03-03 | 2022-03-02 | CYTK | Wong Robert | VP, CAO | F - Tax | $37.63 | -1,447 | 25.8K | -5% | -$54.5K |
| D | 2022-03-03 | 2022-03-02 | CYTK | Wong Robert | VP, CAO | A - Grant | $0.00 | +7,500 | 33.3K | +29% | $0 |
| D | 2022-03-02 | 2022-03-02 | CYTK | COSTA SANTO J | Dir | S - Sale+OE | $37.35 | -10.0K | 5,000 | -67% | -$373.5K |
| D | 2022-03-02 | 2022-03-02 | CYTK | COSTA SANTO J | Dir | M - OptEx | $10.68 | +10.0K | 15.0K | +200% | +$106.8K |
| 2022-03-01 | 2022-02-28 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $35.32 | -3,458 | 153.0K | -2% | -$122.1K | |
| 2022-03-01 | 2022-02-28 | CYTK | Jaw Ching | CFO, SVP Fin | F - Tax | $35.32 | -2,074 | 56.1K | -4% | -$73.3K | |
| 2022-03-01 | 2022-02-28 | CYTK | Blum Robert I | Pres, CEO, Dir | F - Tax | $35.32 | -11.3K | 363.8K | -3% | -$400.1K | |
| 2022-03-01 | 2022-02-28 | CYTK | Cragg David | Chief HR, Admin Off | F - Tax | $35.32 | -2,071 | 142.1K | -1% | -$73.1K | |
| D | 2022-03-01 | 2022-03-01 | CYTK | HENDERSON JOHN T | Dir | M - OptEx | $5.46 | +4,166 | 18.1K | +30% | +$22.7K |
| DM | 2022-02-18 | 2022-02-16 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +14.5K | 375.1K | +4% | $0 |
| D | 2022-02-18 | 2022-02-16 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $36.50 | -10.0K | 360.6K | -3% | -$365.0K |
| D | 2022-02-18 | 2022-02-16 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 370.6K | +3% | +$79.6K |
| M | 2022-02-17 | 2022-02-16 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +5,044 | 3,071 | New | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | Wong Robert | VP, CAO | A - Grant | $0.00 | +1,987 | 27.3K | +8% | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +7,148 | 156.5K | +5% | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | SCHLOSSBERG MARK A | GC, SVP - Legal | A - Grant | $0.00 | +5,025 | 55.9K | +10% | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | Cragg David | Chief HR, Admin Off | A - Grant | $0.00 | +5,008 | 144.2K | +4% | $0 |
| M | 2022-02-17 | 2022-02-16 | CYTK | Jaw Ching | CFO, SVP Fin | A - Grant | $0.00 | +5,022 | 58.2K | +9% | $0 |
| D | 2022-02-09 | 2022-02-07 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $7.96 | +10.0K | 370.6K | +3% | +$79.6K |
Purchase Sale Sale after option exercise All abbreviations